The disease systemic lupus erythematosus SLE -- marked by the attack on joints, skin, and kidneys by the body's immune system -- is linked to an abnormal mix of bacteria in the gut. While bacterial imbalances have been tied to many immune-related diseases, including inflammatory bowel disease, arthritis, and some cancers, the authors of the current study say their experiments are the first detailed evidence of a link between bacterial imbalances in the gut and potentially life-threatening forms of SLE. The new study, publishing in the Annals of Rheumatic Diseases online Feb. Lupus is more common in women than in men. Moreover, study results showed that disease "flares," which can range from instances of skin rash and joint pain to severe kidney dysfunction requiring dialysis, closely tracked major increases in R. Study participants with kidney flares had especially high levels of antibodies to R.
Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients
Lupus Research Paper - Words | Cram
Lupus , technically known as systemic lupus erythematosus SLE , is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. The cause of SLE is not clear. There is no cure for SLE. Rate of SLE varies between countries from 20 to 70 per ,
Research Paper On Lupus
The physician also performs a physical examination of the patient to check the abdomen for suspicious masses or enlarged organs. The physical examination may also include a digital rectal exam DRE. For this exam, the physician checks the rectum for any suspicious masses using a lubricated, gloved finger.
Lupus is an autoimmune disease that affects 1. The immune system becomes hyperactive, attacking healthy tissue while causing inflammation and damage to joints, skin and internal organs. Patients experience a host of symptoms, from extreme fatigue to painful or swollen joints and skin rashes. Current therapies for lupus are toxic and insufficiently effective. Despite the rapid pace of research in immunology, most clinical trials aimed at discovering new therapies in lupus have failed, with only one new drug having been approved in the last five decades.